UTHR logo

UTHR Cash From Operations

Annual CFO:

$1.33B+$349.10M(+35.70%)
December 31, 2024

Summary

  • As of today, UTHR annual cash from operations is $1.33 billion, with the most recent change of +$349.10 million (+35.70%) on December 31, 2024.
  • During the last 3 years, UTHR annual cash from operations has risen by +$728.90 million (+121.85%).
  • UTHR annual cash from operations is now at all-time high.

Performance

UTHR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

Quarterly CFO:

$562.10M+$370.40M(+193.22%)
September 30, 2025

Summary

  • As of today, UTHR quarterly cash from operations is $562.10 million, with the most recent change of +$370.40 million (+193.22%) on September 30, 2025.
  • Over the past year, UTHR quarterly cash from operations has increased by +$187.60 million (+50.09%).
  • UTHR quarterly cash from operations is now at all-time high.

Performance

UTHR Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

TTM CFO:

$1.56B+$187.60M(+13.71%)
September 30, 2025

Summary

  • As of today, UTHR TTM cash from operations is $1.56 billion, with the most recent change of +$187.60 million (+13.71%) on September 30, 2025.
  • Over the past year, UTHR TTM cash from operations has increased by +$419.60 million (+36.92%).
  • UTHR TTM cash from operations is now at all-time high.

Performance

UTHR TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

UTHR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+35.7%+50.1%+36.9%
3Y3 Years+121.8%+117.4%+83.3%
5Y5 Years+742.4%+124.0%+112.6%

UTHR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+121.8%at high+428.8%at high+95.8%
5Y5-Yearat high+742.4%at high+526.0%at high+183.9%
All-TimeAll-Timeat high+742.4%at high+189.6%at high+853.2%

UTHR Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$562.10M(+193.2%)
$1.56B(+13.7%)
Jun 2025
-
$191.70M(-58.4%)
$1.37B(-2.9%)
Mar 2025
-
$461.20M(+35.2%)
$1.41B(+6.4%)
Dec 2024
$1.33B(+35.7%)
$341.20M(-8.9%)
$1.32B(+16.5%)
Sep 2024
-
$374.50M(+61.3%)
$1.14B(+2.6%)
Jun 2024
-
$232.20M(-38.3%)
$1.11B(+12.8%)
Mar 2024
-
$376.50M(+145.4%)
$982.40M(+0.4%)
Dec 2023
$978.00M(+21.9%)
$153.40M(-55.7%)
$978.00M(+3.5%)
Sep 2023
-
$346.20M(+225.7%)
$945.30M(+10.2%)
Jun 2023
-
$106.30M(-71.4%)
$857.70M(-2.4%)
Mar 2023
-
$372.10M(+208.3%)
$878.40M(+10.5%)
Dec 2022
$802.50M(+34.2%)
$120.70M(-53.3%)
$795.00M(-6.3%)
Sep 2022
-
$258.60M(+103.6%)
$848.90M(+9.4%)
Jun 2022
-
$127.00M(-56.0%)
$775.90M(-2.7%)
Mar 2022
-
$288.70M(+65.3%)
$797.10M(+33.2%)
Dec 2021
$598.20M(-20.8%)
$174.60M(-5.9%)
$598.20M(+9.1%)
Sep 2021
-
$185.60M(+25.2%)
$548.10M(-10.6%)
Jun 2021
-
$148.20M(+65.0%)
$613.40M(-2.5%)
Mar 2021
-
$89.80M(-27.9%)
$629.20M(-16.6%)
Dec 2020
$755.70M(+465.8%)
$124.50M(-50.4%)
$754.00M(+3.0%)
Sep 2020
-
$250.90M(+53.0%)
$732.00M(+9.8%)
Jun 2020
-
$164.00M(-23.6%)
$666.50M(+4.9%)
Mar 2020
-
$214.60M(+109.4%)
$635.40M(+407.6%)
Dec 2019
-$206.60M(-126.5%)
$102.50M(-44.7%)
-$206.60M(-8.3%)
Sep 2019
-
$185.40M(+39.5%)
-$190.70M(-11.1%)
Jun 2019
-
$132.90M(+121.2%)
-$171.60M(-37.6%)
Mar 2019
-
-$627.40M(-629.9%)
-$124.70M(-116.0%)
Dec 2018
$778.40M(+64.2%)
$118.40M(-42.1%)
$778.40M(+35.6%)
Sep 2018
-
$204.50M(+13.7%)
$574.20M(-8.6%)
Jun 2018
-
$179.80M(-34.8%)
$628.20M(+21.0%)
Mar 2018
-
$275.70M(+421.3%)
$519.10M(+9.5%)
Dec 2017
$474.20M(-26.3%)
-$85.80M(-133.2%)
$474.20M(-34.4%)
Sep 2017
-
$258.50M(+265.6%)
$723.40M(+4.3%)
Jun 2017
-
$70.70M(-69.4%)
$693.60M(-7.3%)
Mar 2017
-
$230.80M(+41.2%)
$748.60M(+16.3%)
Dec 2016
$643.60M(+68.1%)
$163.40M(-28.6%)
$643.60M(+27.3%)
Sep 2016
-
$228.70M(+81.9%)
$505.71M(+4.4%)
Jun 2016
-
$125.70M(-0.1%)
$484.33M(+21.2%)
Mar 2016
-
$125.80M(+393.0%)
$399.61M(+4.4%)
Dec 2015
$382.80M(+7.7%)
$25.52M(-87.7%)
$382.76M(-14.5%)
Sep 2015
-
$207.31M(+405.9%)
$447.85M(-0.3%)
Jun 2015
-
$40.98M(-62.4%)
$449.07M(+27.0%)
Mar 2015
-
$108.95M(+20.2%)
$353.61M(-0.5%)
Dec 2014
$355.30M(-16.5%)
$90.61M(-56.6%)
$355.26M(-3.7%)
Sep 2014
-
$208.54M(+482.8%)
$369.07M(+23.1%)
Jun 2014
-
-$54.48M(-149.3%)
$299.84M(-31.6%)
Mar 2014
-
$110.60M(+5.9%)
$438.17M(+3.0%)
Dec 2013
$425.27M(+31.4%)
$104.42M(-25.0%)
$425.27M(-0.2%)
Sep 2013
-
$139.30M(+66.1%)
$426.06M(+12.1%)
Jun 2013
-
$83.85M(-14.2%)
$380.20M(-0.9%)
Mar 2013
-
$97.70M(-7.1%)
$383.74M(+18.6%)
Dec 2012
$323.63M
$105.21M(+12.6%)
$323.63M(+19.8%)
Sep 2012
-
$93.45M(+6.9%)
$270.05M(+5.0%)
Jun 2012
-
$87.39M(+132.5%)
$257.28M(+9.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
$37.59M(-27.2%)
$234.43M(-6.3%)
Dec 2011
$250.19M(+18.3%)
$51.63M(-36.0%)
$250.19M(+5.2%)
Sep 2011
-
$80.68M(+25.0%)
$237.82M(-8.5%)
Jun 2011
-
$64.54M(+21.0%)
$259.97M(+12.7%)
Mar 2011
-
$53.35M(+35.9%)
$230.66M(+9.0%)
Dec 2010
$211.53M(+112.1%)
$39.25M(-61.8%)
$211.53M(+7.8%)
Sep 2010
-
$102.83M(+191.9%)
$196.26M(+79.4%)
Jun 2010
-
$35.23M(+3.0%)
$109.42M(-16.2%)
Mar 2010
-
$34.22M(+42.7%)
$130.54M(+33.7%)
Dec 2009
$99.72M(+302.7%)
$23.98M(+50.0%)
$97.62M(+271.5%)
Sep 2009
-
$15.99M(-71.6%)
-$56.91M(+1.7%)
Jun 2009
-
$56.35M(+4228.0%)
-$57.92M(+30.1%)
Mar 2009
-
$1.30M(+101.0%)
-$82.90M(-68.6%)
Dec 2008
-$49.20M(-200.5%)
-$130.55M(-971.7%)
-$49.17M(-170.4%)
Sep 2008
-
$14.98M(-52.3%)
$69.87M(-14.9%)
Jun 2008
-
$31.38M(-10.4%)
$82.15M(+15.7%)
Mar 2008
-
$35.03M(+404.3%)
$70.97M(+44.6%)
Dec 2007
$48.95M(-0.9%)
-$11.51M(-142.2%)
$49.08M(-13.1%)
Sep 2007
-
$27.26M(+34.9%)
$56.48M(+18.3%)
Jun 2007
-
$20.20M(+53.7%)
$47.76M(-1.4%)
Mar 2007
-
$13.14M(+419.2%)
$48.44M(-6.5%)
Dec 2006
$49.39M(+14.4%)
-$4.12M(-122.2%)
$51.78M(-19.1%)
Sep 2006
-
$18.54M(-11.2%)
$64.01M(+5.5%)
Jun 2006
-
$20.88M(+26.7%)
$60.65M(+10.2%)
Mar 2006
-
$16.48M(+103.3%)
$55.03M(+25.9%)
Dec 2005
$43.17M(+107.7%)
$8.11M(-46.6%)
$43.70M(+12.4%)
Sep 2005
-
$15.19M(-0.5%)
$38.89M(+16.6%)
Jun 2005
-
$15.26M(+196.2%)
$33.36M(+30.4%)
Mar 2005
-
$5.15M(+56.2%)
$25.59M(+23.2%)
Dec 2004
$20.78M(+342.7%)
$3.30M(-65.9%)
$20.78M(+229.2%)
Sep 2004
-
$9.66M(+29.0%)
$6.31M(+515.7%)
Jun 2004
-
$7.49M(+2114.8%)
$1.02M(+113.2%)
Mar 2004
-
$338.00K(+103.0%)
-$7.79M(+9.0%)
Dec 2003
-$8.56M(+61.5%)
-$11.17M(-355.5%)
-$8.56M(-397.5%)
Sep 2003
-
$4.37M(+427.9%)
$2.88M(+135.1%)
Jun 2003
-
-$1.33M(-210.0%)
-$8.19M(+42.2%)
Mar 2003
-
-$430.00K(-259.3%)
-$14.17M(+36.3%)
Dec 2002
-$22.26M(+42.8%)
$270.00K(+104.0%)
-$22.26M(+25.6%)
Sep 2002
-
-$6.70M(+8.4%)
-$29.91M(+15.0%)
Jun 2002
-
-$7.31M(+14.2%)
-$35.18M(+9.4%)
Mar 2002
-
-$8.52M(-15.5%)
-$38.82M(+0.2%)
Dec 2001
-$38.90M(-25.0%)
-$7.38M(+38.4%)
-$38.90M(+6.4%)
Sep 2001
-
-$11.97M(-9.3%)
-$41.54M(-19.8%)
Jun 2001
-
-$10.96M(-27.5%)
-$34.67M(-6.3%)
Mar 2001
-
-$8.59M(+14.2%)
-$32.61M(-4.8%)
Dec 2000
-$31.11M(-31.3%)
-$10.02M(-96.6%)
-$31.11M(-8.2%)
Sep 2000
-
-$5.10M(+42.7%)
-$28.75M(+1.5%)
Jun 2000
-
-$8.89M(-25.2%)
-$29.18M(-5.1%)
Mar 2000
-
-$7.10M(+7.2%)
-$27.77M(-17.2%)
Dec 1999
-$23.70M(-146.9%)
-$7.66M(-38.5%)
-$23.69M(-47.7%)
Sep 1999
-
-$5.53M(+26.1%)
-$16.04M(-52.6%)
Jun 1999
-
-$7.48M(-147.2%)
-$10.51M(-247.2%)
Mar 1999
-
-$3.03M
-$3.03M
Dec 1998
-$9.60M
-
-

FAQ

  • What is United Therapeutics Corporation annual cash from operations?
  • What is the all-time high annual cash from operations for United Therapeutics Corporation?
  • What is United Therapeutics Corporation annual cash from operations year-on-year change?
  • What is United Therapeutics Corporation quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for United Therapeutics Corporation?
  • What is United Therapeutics Corporation quarterly cash from operations year-on-year change?
  • What is United Therapeutics Corporation TTM cash from operations?
  • What is the all-time high TTM cash from operations for United Therapeutics Corporation?
  • What is United Therapeutics Corporation TTM cash from operations year-on-year change?

What is United Therapeutics Corporation annual cash from operations?

The current annual cash from operations of UTHR is $1.33B

What is the all-time high annual cash from operations for United Therapeutics Corporation?

United Therapeutics Corporation all-time high annual cash from operations is $1.33B

What is United Therapeutics Corporation annual cash from operations year-on-year change?

Over the past year, UTHR annual cash from operations has changed by +$349.10M (+35.70%)

What is United Therapeutics Corporation quarterly cash from operations?

The current quarterly cash from operations of UTHR is $562.10M

What is the all-time high quarterly cash from operations for United Therapeutics Corporation?

United Therapeutics Corporation all-time high quarterly cash from operations is $562.10M

What is United Therapeutics Corporation quarterly cash from operations year-on-year change?

Over the past year, UTHR quarterly cash from operations has changed by +$187.60M (+50.09%)

What is United Therapeutics Corporation TTM cash from operations?

The current TTM cash from operations of UTHR is $1.56B

What is the all-time high TTM cash from operations for United Therapeutics Corporation?

United Therapeutics Corporation all-time high TTM cash from operations is $1.56B

What is United Therapeutics Corporation TTM cash from operations year-on-year change?

Over the past year, UTHR TTM cash from operations has changed by +$419.60M (+36.92%)
On this page